Join PDC Line Pharma at AACR 2024

Mar 29, 2024

Posted by Wallonia Trade and Investment

An exciting development awaits at the upcoming American Association for Cancer Research Annual Meeting 2024 in San Diego!

The Consulate General of Belgium in New York is thrilled to announce that PDC Line Pharma, a dynamic Walloon biotech company, is set to reveal groundbreaking findings in therapeutic vaccines for stage IV Non-Small Cell Lung Cancer at the AACR Annual Meeting 2024.

PDC Line Pharma has been selected to unveil the initial findings of its clinical study, presenting a rare opportunity to gain insights into the future of cancer research innovation. Led by CEO Eric Halioua and CSO Joël Plumas, this presentation promises to shed light on the company’s cutting-edge clinical and financial objectives.



🗓️ Date: April 7th, 2024

🕒 Time: 3:00 PM PDT

📍 Location: Ballroom 20 AB – Upper Level – San Diego Convention Center


Reach out to Eric or Joël during or after the event to delve deeper into our PDC Line Pharma’s future goals and discuss the latest results of their ongoing clinical trial in NSCLC.


President & Chief Executive Officer
PDC*line Pharma
Cell: +32 474 05 78 66


Economic and Commercial Counselor 

Wallonia Export & Investment (AWEX)

Consulate General of Belgium 

885 Second Avenue – Fl. 41

New York, NY 10017

T: 212-247-6351

Cell: 929-841-4818



Download Attachment

See all Member News